Manager Network and Events, Healthcare Innovation - DayOne
Tel. +41 61 295 50 16thomas. brenzikofer@baselarea. swiss
The city of Basel is represented in a list of the world’s 100 most valuable companies. The Basel-based pharmaceutical companies Roche and Novartis were able to repeat their strong results from 2015.
A total of three Swiss corporations are among the 100 most valuable companies in the world. According to the latest findings from the global consultancy firm EY, Nestlé came in 21st place in the international ranking with a value of USD 214 billion (CHF 218 billion). The Basel-based pharmaceutical company Roche came in 28th with a market value of USD 194 billion, followed by Basel’s Novartis in 35th with USD 171 billion. This puts Switzerland in seventh place after the US, China, the UK, Germany, France and Japan.
Roche and Novartis came in 14th and 19th one year ago in the global ranking, which, like this year, placed them in second and third place in Switzerland behind Nestlé. While these are the only three Swiss companies to make it into the top 100, a total of ten companies from Switzerland are in the top 300.
In a global comparison, the US is the undisputed frontrunner with 57 companies in the list. Its technology companies Apple (USD 625 billion), the Google holding company Alphabet (USD 552 billion) and Microsoft (USD 492 billion) are also the three most valuable corporations in the world. The world’s top ranked pharmaceutical company, Johnson & Johnson (USD 315 billion), also comes from the US. It came in ninth place last year and is now ranked eighth.
The ranking of the top seven companies has not changed in the past two years. Among the top 100 are a total of 16 companies from the healthcare industry.